Informação sobre produto
Nome:
Sovaprevir
Sinónimos:
- 2-Pyrrolidinecarboxamide
- ACH 0141625
- 2-Pyrrolidinecarboxamide, N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2S,4R)-
Descrição:
Sovaprevir is a protease inhibitor that blocks the activity of NS3, an enzyme involved in the replication of the hepatitis C virus. It binds to the active site of NS3 and prevents cleavage of NS3-specific substrates. Sovaprevir also inhibits viral kinetics by binding to the envelope protein gp41 on the surface of HIV. Sovaprevir is an orally administered drug that can be used for treatment or prevention of both chronic and acute hepatitis C, as well as HIV infection. Sovaprevir is a potent inhibitor of serine proteases, including HIV protease, and has anti-cancer properties.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
